Entecavir for hepatitis B virus flare treatment in patients with Crohn's disease

Hepato-Gastroenterology

Volumn 57, Issue 98, 2010, Pages 242-245

  Sacco, Rodolfo ^a,b   Bertini, Marco ^a   Bresci, Giampaolo ^a   Romano, Antonio ^a   Altomare, Emanuele ^b   Capria, Alfonso ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Antiviral agents; Crohn's disease; Entecavir; Hepatitis B virus

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; ENTECAVIR; IMMUNOSUPPRESSIVE AGENT; MEPREDNISONE; MESALAZINE; VIRUS DNA;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; COMORBIDITY; CORTICOSTEROID THERAPY; CROHN DISEASE; DECOMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; DISEASE EXACERBATION; DIURETIC THERAPY; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; LIVER FUNCTION; MALE; NONHUMAN; PARENTERAL NUTRITION; PRIORITY JOURNAL; TREATMENT OUTCOME; VIREMIA; VIRUS HEPATITIS;

AGED; ANTIVIRAL AGENTS; CROHN DISEASE; DIURETICS; GUANINE; HEPATITIS B, CHRONIC; HUMANS; LIVER FUNCTION TESTS; MALE; PARENTERAL NUTRITION, TOTAL; TREATMENT OUTCOME;

EID: 77954116654     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dienstag JL: Hepatitis B virus infection. N Engl J Med 2008 Oct 2; 359(14): 1486-1500. (PMID: 18832247 DOI: 10.1056/NEJMra0801644]
2. Pungpapong S, Kim WR, Poterucha JJ: Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 2007; 82(8): 967-975. [PMID: 17673066 DOI: 10.4065/82.8.967]
3. Biancone L, Pavia M, Del Vecchio Blanco G et al: Hepatitis B and C virus infection in Crohn's disease. Inflamm Bowel Dis 2001; 7(4): 287-294. [PMID: 11720317 DOI: 10.1097/00054725-200111000-00002]
4. Perrillo RP: Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001; 120(4): 1009-1022. [PMID: 11231956 DOI: S0016508501668598]
5. Tur-Kaspa R, Shaul Y, Moore DD et al: The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. Virology 1988 Dec; 167(2): 630-633. [PMID: 3201757]
6. del Valle Garcia-Sanchez M, Gomez-Camacho F, Poyato-GonzalezA et al: Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection. Inflamm Bowel Dis 2004; 10(5): 701-702. [PMID: 15472541 DOI: 10.1097/00054725-200409000-00035]
7. Ueno Y, Tanaka S, Shimamoto M, Miyanaka Y, Hiyama T, Ito M, Kitadai Y, Yoshihara M, Sumii M, Chayama K: Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B. Dig Dis Sci 2005 Jan; 50(1): 163-166. [PMID: 15712655 DOI: 10.1007/s10620-005-1295-8]
8. Laskus T, Slusarczyk J, Cianciara J, Loch T: Exacerbation of chronic active hepatitis type B after short-term corticosteroid therapy resulting in fatal liver failure. Am J Gastroenterol 1990; 85(10): 1414-1417. [PMID: 2220740] (Pubitemid 20360660)
9. Rakela J, Redeker AG, Weliky B: Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. Gastroenterology 1983 ; 84(5 Pt 1): 956-960. [PMID: 6832570 DOI: S001650858300116X] (Pubitemid 13119909)
10. Esteve M, Saro C, Gonzalez-Huix F, Suarez F, Forne M, Viver JM: Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 2004 ; 53(9): 1363-1365. [PMID: 15306601 DOI: 10.1136/gut.2004.040675]
11. Millonig G, Kern M, Ludwiczek O, Nachbaur K, Vogel W: Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening? World J Gastroenterol 2006; 12(6): 974-976. [PMID: 16521231]
12. Ojiro K, Naganuma M, Ebinuma H, Kunimoto H et al: Reactivation of hepatitis B in a patient with Crohn's disease treated using infliximab. J Gastroenterol 2008; 43(5): 397-401. [PMID: 18592158 DOI: 10.1007/s00535-008- 2165-x]
13. Ahmed A, Keeffe EB: Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection. Am J Gastroenterol 1999 ; 94(1): 249-251. [PMID: 9934765 DOI: S0002927098006893]
14. Clark FL, Drummond MW, Chambers S, Chapman BA, Patton WN: Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma. Ann Oncol 1998 9(4): 385-387. [PMID: 9636828 DOI: 10.1023/A:1008206519571]
15. Maguire CM, Crawford DH, Hourigan LF, Clouston AD, Walpole ET, Powell EE: Case report: lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy. J Gastroenterol Hepatol 1999 ; 14(8): 801-803. [PMID: 10482432 DOI: 10.1046/j.1440-1746.1999.01961.x]
16. Yeo W, Steinberg JL, Tam JS, Chan PK, Leung NW, Lam KC, Mok TS, Johnson PJ: Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy. J Med Virol 1999 Nov; 59(3): 263-269. [PMID: 10502254 DOI: 10.1002/(SICI)1096-9071(199911)59:3〈263:AID-JMV1〉3.0.CO;2-X]
17. Dusheiko G, Antonakopoulos N: Current treatment of hepatitis B. Gut 2008 Jan; 57(1): 105-124. [PMID: 17502343 DOI: 10.1136/gut.2005.077891]
18. Colonno RJ, Rose R, Baldick CJ, Levine S et al: Entecavir resistance is rare in nucleoside naive patients with hepatitis B. Hepatology 2006 ; 44(6): 1656-1665. [PMID: 17133475 DOI: 10.1002/hep.21422]
19. Chang TT, Gish RG, de Man R, Gadano A et al: A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006 ; 354(10): 1001-1010. [PMID: 16525137 DOI: 10.10567NEJMoa051285]
20. Lai CL, Shouval D, Lok AS, Chang TT et al: Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med 2006 ; 354(10): 1011-1020. [PMID: 16525138 DOI: 10.1056/NEJMoa051287]